3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE

Mix E, Ibrahim SM, Pahnke J, Glass Ä, Mazon-Pelafz I, Lemcke S, Koczan D, Gimsa U, Bansemeyer S, Scheel T, Koropka T, et al. (2006)
Journal of Autoimmunity 27(4): 251-265.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Erscheinungsjahr
Zeitschriftentitel
Journal of Autoimmunity
Band
27
Zeitschriftennummer
4
Seite
251-265
ISSN
PUB-ID

Zitieren

Mix E, Ibrahim SM, Pahnke J, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. Journal of Autoimmunity. 2006;27(4):251-265.
Mix, E., Ibrahim, S. M., Pahnke, J., Glass, Ä., Mazon-Pelafz, I., Lemcke, S., Koczan, D., et al. (2006). 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. Journal of Autoimmunity, 27(4), 251-265. doi:10.1016/j.jaut.2006.09.006
Mix, E., Ibrahim, S. M., Pahnke, J., Glass, Ä., Mazon-Pelafz, I., Lemcke, S., Koczan, D., Gimsa, U., Bansemeyer, S., Scheel, T., et al. (2006). 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. Journal of Autoimmunity 27, 251-265.
Mix, E., et al., 2006. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. Journal of Autoimmunity, 27(4), p 251-265.
E. Mix, et al., “3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE”, Journal of Autoimmunity, vol. 27, 2006, pp. 251-265.
Mix, E., Ibrahim, S.M., Pahnke, J., Glass, Ä., Mazon-Pelafz, I., Lemcke, S., Koczan, D., Gimsa, U., Bansemeyer, S., Scheel, T., Koropka, T., Böttcher, T., Müller, J., Dazert, E., Antipova, V., Hoffrogge, R., Wree, A., Zschiesche, M., Strauss, U., Kundt, G., Warzok, R., Gierl, L., Rolfs, A.: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. Journal of Autoimmunity. 27, 251-265 (2006).
Mix, Eilhard, Ibrahim, S.M., Pahnke, Jens, Glass, Änne, Mazon-Pelafz, I., Lemcke, S., Koczan, D., Gimsa, U., Bansemeyer, S., Scheel, T., Koropka, T., Böttcher, T., Müller, J., Dazert, E., Antipova, V., Hoffrogge, Raimund, Wree, A., Zschiesche, M., Strauss, U., Kundt, G., Warzok, R., Gierl, L., and Rolfs, Arndt. “3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE”. Journal of Autoimmunity 27.4 (2006): 251-265.

6 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Statins alleviate experimental nerve injury-induced neuropathic pain.
Shi XQ, Lim TK, Lee S, Zhao YQ, Zhang J., Pain 152(5), 2011
PMID: 21414721
Animal models of multiple sclerosis--potentials and limitations.
Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK., Prog Neurobiol 92(3), 2010
PMID: 20558237
The mosaic of autoimmunity.
Gershwin ME., Autoimmun Rev 7(3), 2008
PMID: 18190871
One year in autoimmunity.
Selmi C., Autoimmun Rev 7(1), 2007
PMID: 17967731

55 References

Daten bereitgestellt von Europe PubMed Central.

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D., J. Neuroimmunol. 152(1-2), 2004
PMID: 15223248
Mechanisms of action of glatiramer acetate in multiple sclerosis.
Neuhaus O, Farina C, Wekerle H, Hohlfeld R., Neurology 56(6), 2001
PMID: 11288751
Gene regulation and DNA damage in the ageing human brain.
Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA., Nature 429(6994), 2004
PMID: 15190254
Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZ., J. Neuroimmunol. 152(1-2), 2004
PMID: 15223245
Development of biomarkers in multiple sclerosis.
Bielekova B, Martin R., Brain 127(Pt 7), 2004
PMID: 15180926

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 17085013
PubMed | Europe PMC

Suchen in

Google Scholar